MapMyGenome launches affordable pharmacogenomics solution MedicaMap

06 December 2022 | News

Pharmacogenomics solution MedicaMap covers more than 165 drugs

image credit- prnewswire

image credit- prnewswire

Hyderabad-based MapMyGenome has launched its pharmacogenomics solution MedicaMap.

MedicaMap is MapMyGenome's cutting-edge pharmacogenomic solution that analyses an individual's response to medicines, based on genetic makeup. This pharmacogenomic solution analyses 165+ US-FDA-approved drugs across 12 different specialties such as psychiatry, oncology, cardiology, diabetology, and many more.

Dr Annie Q Hasan, Founder & President of the Board of Genetic Counseling India said, "Medicines are usually prescribed using a 'one-size-fits-all' approach. But variations in individuals' DNA lead to variations in their response to medication."

MapMyGenome CEO Anu Acharya said, "MedicaMap is a one of a kind  phamacogenomic product which provides you detailed analysis of your body's response to medicine based on your genetic makeup.

It is affordable, non-invasive, once-in-a lifetime. You can do it from your own home. We have introduced it at Rs 6499 for over 165 drugs, which is probably the lowest price."

MedicaMap covers common medicines like metformin, clopidogrel, warfarin, codeine, and many other medicines commonly used by Indians. It gives an easy-to-read comprehensive report on medicines' toxicity and efficacy for a person. It helps clinicians to identify alternate medicine or adjust the dosage according to an individual's genetic profile for the prevention, diagnosis, and treatment of any health condition.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account